AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19085526
Drug: Internet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet treatment
Trial: 15498183
Drug: Metformin 500
RxNorm normalized name: metformin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 500 mg three times daily for 3 months (Group Aa)
Trial: 15498183
Drug: Clomiphene 50
RxNorm normalized name: clomiPHENE 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene 50 mg once daily for 5 days and 3 cycles (Group Ab)
Trial: 15498183
Drug: Metformin and
RxNorm normalized name: metformin and acarbose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin and clomiphene (Group Ac)
Trial: 11133901
Drug: Alpha-blocker (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-blocker (3 mg/day prazosin)
Trial: 9620105
Drug: Oral sulfonylureas
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sulfonylureas
Trial: 8131544
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 600 mg orally 3 times a day for 15 days
Trial: 8131544
Drug: In vitro
RxNorm normalized name: glucuronidase in vitro test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vitro NAC treatment at 10 micrograms/ml
Trial: 2675219
Drug: Morphine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (50 micrograms/kg)
Trial: 817373
Drug: Synthetic TRH
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic TRH (300 mg/day)
Trial: 28367636
Drug: Sensor augmented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensor augmented insulin pump therapy (open loop) for 12 weeks
Trial: 25040098
Drug: 3% praziquantel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% praziquantel (PZQ) ointment
Trial: 25040098
Drug: Placebo (vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (vehicle ointment)
Trial: 19120432
Drug: Insulin Aspart
RxNorm normalized name: Insulin Aspart
DrugBank: Insulin aspart (DB01306)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin Aspart (IAsp) 0.3 U/kg
Trial: 15881046
Drug: Cognitive Orientation
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Orientation to daily Occupational Performance (CO‐OP)
Trial: 11471396
Drug: Contemporary Treatment
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Contemporary Treatment Approach (CTA)
Trial: 9693393
Drug: Intravenous clomipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous clomipramine (12.5 mg, i.v.)
Trial: 9693393
Drug: Oral clomipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral clomipramine after i.v. challenge
Trial: 2126915
Drug: Budesonide (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (200 micrograms, topical corticosteroid)
Trial: 2126915
Drug: Ibuprofen (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (600 mg, cyclooxygenase inhibitor)
Trial: 22430025
Drug: Fluoroscopic-guided injection
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoroscopic-guided injection
Trial: 18606285
Drug: Other treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other treatments (painted center line, post-delineators)
Trial: 15811482
Drug: Vasopressor group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vasopressor group (33 patients) with controlled fluid administration
Trial: 15811482
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (32 patients) with fluid administration only
Trial: 19732200
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy (HDC)
Trial: 11821456
Drug: Standard-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose chemotherapy (SDC)
Trial: 11149796
Drug: Permanent magnetic
RxNorm normalized name: MAGNESIA
DrugBank: Magnesium oxide (DB01377)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Permanent magnetic field therapy (magnets in the form of patches)
Trial: 11149796
Drug: Sham magnet
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sham magnet patches (control group)
Trial: 1485658
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg terfenadine
Trial: 1591463
Drug: Matched placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched placebo tablet
Trial: 6377715
Drug: Prophylactic administration
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic administration of immunoglobulins (Intragam)
Trial: 6377715
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no immunoglobulin administration)
Trial: 19416932
Drug: Dorzolamide-timolol combination
RxNorm normalized name: dorzolamide / timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide-timolol combination
Trial: 12002666
Drug: Timolol monotherapy
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol monotherapy
Trial: 19416932
Drug: Dorzolamide-timolol combination
RxNorm normalized name: dorzolamide / timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dorzolamide-timolol combination to Timolol monotherapy
Trial: 17803343
Drug: Topiramate adjunctive
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate adjunctive therapy
Trial: 11256837
Drug: Oral doxifluridine
RxNorm normalized name: Trifluridine
DrugBank: Trifluridine (DB00432)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral doxifluridine (700 mg/m2/day) and leucovorin (20 mg/m2) daily during radiation treatment (n = 14)
Trial: 11256837
Drug: Oral doxifluridine
RxNorm normalized name: Trifluridine
DrugBank: Trifluridine (DB00432)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral doxifluridine
Trial: 11256837
Drug: Intravenous 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous 5-fluorouracil (5-FU)
Trial: 3780584
Drug: 4 l
RxNorm normalized name: PEG-4 laurate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 l Golytely (GOL)
Trial: 3780584
Drug: Balanced Electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balanced Electrolyte Solution (BES)
Trial: 24742658
Drug: elevated cFLC
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: elevated cFLC (>57.2 mg/L)
Trial: 20496736
Drug: Acupoint sticking
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint sticking therapy with ginger moxibustion at Dazhui (GV 14) and Feishu (BL 13) applied once at specified intervals based on seasonal timing.
Trial: 20496736
Drug: Acupoint sticking
RxNorm normalized name: Zit Stick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupoint sticking therapy with ginger moxibustion at Dazhui (GV 14) and Feishu (BL 13) applied once every other 10 days during 30 days.
Trial: 16249929
Drug: Diphtheria-tetanus vaccine
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus vaccine (DT) with 40 microg of pertussis toxoid (DTaP40)
Trial: 16249929
Drug: Diphtheria-tetanus vaccine
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus vaccine (DT) with 20 microg or 40 microg of pertussis toxoid
Trial: 16249929
Drug: Diphtheria-tetanus vaccine
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus vaccine (DT) alone or with pertussis toxoid
Trial: 16249929
Drug: Diphtheria-tetanus vaccine
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphtheria-tetanus vaccine (DT)
Trial: 2268862
Drug: Ketoprofen 50
RxNorm normalized name: ketoprofen 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 50 mg
Trial: 12534583
Drug: Paracetamol 500
RxNorm normalized name: Paracetamol 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 500 mg
Trial: 8665578
Drug: Ketoprofen 25
RxNorm normalized name: ketoprofen 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 25 mg (2 x 25 mg)
Trial: 1449335
Drug: Enoximone 100
RxNorm normalized name: enoximone
DrugBank: Enoximone (DB04880)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone 100 mg three times a day orally (Group E)
Trial: 29862945
Drug: MPT64 patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPT64 patch test
Trial: 19666152
Drug: Cell-culture-derived influenza
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cell-culture-derived influenza vaccine (CCIV)
Trial: 19673651
Drug: Conventional egg-based
RxNorm normalized name: EGG
DrugBank: Egg (DB10529)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional egg-based vaccine
Trial: 15327583
Drug: Intra-arterial ALA
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial ALA (incremental cumulative doses of 0.5, 1.0, 1.5 and 2.0 mg ml(‐1) min(‐1))
Trial: 15327583
Drug: Plasma ALA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma ALA after oral supplementation
Trial: 9066509
Drug: Bioresonance therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bioresonance therapy (BIT)
Trial: 9066509
Drug: Sham (placebo)
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham (placebo) BIT treatment
Trial: 3005384
Drug: Captopril, 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril, 200 mg every 12 hours (n = 9)
Trial: 3005384
Drug: Enalapril maleate,
RxNorm normalized name: Enalapril Maleate, 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril maleate, 20 mg every 12 hours (n = 11)
Trial: 29862568
Drug: Routine medication
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine medication
Trial: 25041141
Drug: CVS brand
RxNorm normalized name: Eagle Brand Medicated Oil
DrugBank: Eucalyptus oil (DB11114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVS brand antacid
Trial: 21967854
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids (1.4 g EPA and DHA)
Trial: 20355261
Drug: 6 of
RxNorm normalized name: CLN2 RDNA CONSTRUCT DISRUPTING EXON 6 OF CLN2 GENE IN YUCATAN MINIATURE SWINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 of the 9 treatments
Trial: 2007669
Drug: Terbinafine, 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbinafine, 250 mg twice daily for 6 weeks
Trial: 2007669
Drug: Griseofulvin, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Griseofulvin, 500 mg twice daily for 6 weeks
Trial: 25195020
Drug: Treatment according
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment according to the GermanIMPACT model
Trial: 2203327
Drug: MK-212 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-212 (20 mg)
Trial: 28397984
Drug: 12-month multifactorial
RxNorm normalized name: moth bean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-month multifactorial intervention by primary care nurses including motivational interviews and individualized physical activity prescriptions.
Trial: 26187089
Drug: Friends Helping
RxNorm normalized name: Fisherman's Friend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Friends Helping Friends program (treatment group)
Trial: 23993298
Drug: VesCell therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VesCell therapy
Trial: 9767199
Drug: Buprenorphine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (8 mg max dose)
Trial: 9767199
Drug: Methadone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (60 mg equivalent, free dosing schedule)
Trial: 2977280
Drug: Fenfluramine treatment
RxNorm normalized name: fenfluramine
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenfluramine treatment
Trial: 30640206
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (2.5 g per day)
Trial: 15214873
Drug: Telithromycin 800
RxNorm normalized name: Telithromycin
DrugBank: Telithromycin (DB00976)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telithromycin 800 mg once-daily for 5 days
Trial: 15214873
Drug: Clarithromycin 250
RxNorm normalized name: clarithromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 250 mg twice-daily for 10 days (Control)
Trial: 8347731
Drug: Ubenimex (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ubenimex (30 mg orally once a day during maintenance therapy)
Trial: 2872803
Drug: Terazosin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (1 to 40 mg daily)
Trial: 22302530
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E administration (400 IU/day p.o.)
Trial: 7787467
Drug: Optimal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal therapy for acute myocardial infarction
Trial: 820214
Drug: Coarse mesh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coarse mesh gauze, changed three times daily
Trial: 11464350
Drug: Gabapentin 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 1,200 mg
Trial: 12734762
Drug: Maprotiline 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maprotiline 60 mg daily for 6 months
Trial: 17310047
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy (continuous insulin infusion to maintain intraoperative glucose levels between 4.4 and 5.6 mmol/L)
Trial: 17310047
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (no insulin unless glucose > 11.1 mmol/L)
Trial: 10755315
Drug: Cisplatin (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (70 mg/m2 on day 1), ifosfamide (1.5 g/m2 on days 1-4), irinotecan (60 mg/m2 on days 1, 8, and 15), with rhG-CSF (1 microg/kg on days 5-18)
Trial: 10755315
Drug: Cisplatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (80 mg/m2)
Trial: 7717282
Drug: Ibopamine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibopamine (100 mg 3 times daily)
Trial: 2049963
Drug: Oral absorbable
RxNorm normalized name: COLLAGEN HEMOSTAT,ABSORBABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral absorbable antibiotics (ofloxacin 400 mg/day and amoxicillin 20 g/day)
Trial: 2049963
Drug: Oral nonabsorbable
RxNorm normalized name: COLLAGEN HEMOSTAT,ABSORBABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nonabsorbable antibiotics (vancomycin 450 mg/day, tobramycin 450 mg/day, and colistin 4.5 x 10^6 units daily)
Trial: 17931461
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Vildagliptin 100 mg and Simvastatin 80 mg
Trial: 21281406
Drug: Mebendazole (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebendazole (500 mg single dose)
Trial: 9497178
Drug: 10.2 g
RxNorm normalized name: IODINE 10.2 g in 1 L TOPICAL SOLUTION [Proteat]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10.2 g psyllium seed husk (PSH)/d
Trial: 9497178
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 g PSH/d)
Trial: 9497178
Drug: 3.4 g
RxNorm normalized name: psyllium 3.4 g oral wafer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.4 g psyllium seed husk (PSH)/d
Trial: 9497178
Drug: 6.8 g
RxNorm normalized name: Veltassa 16.8 GM Powder for Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.8 g psyllium seed husk (PSH)/d
Trial: 7710954
Drug: Melatonin (MLT)
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin (MLT) 20 mg orally daily starting 7 days before tamoxifen (TMX)
Trial: 7710954
Drug: Tamoxifen (TMX)
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen (TMX) 20 mg orally daily
Trial: 17879543
Drug: Qingbi Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qingbi Tablet (Chinese herbal preparation)
Trial: 7851263
Drug: Intensified conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified conventional treatment
Trial: 26444986
Drug: Luseogliflozin 20
RxNorm normalized name: luseogliflozin
DrugBank: Luseogliflozin (DB12214)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Luseogliflozin 20 mg
Trial: 22287376
Drug: 2 mL
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mL 0.25% bupivacaine with epinephrine 1:100,000 (BP)
Trial: 19695030
Drug: Olmesartan 40
RxNorm normalized name: HCTZ 25/OLMESARTAN 40MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 40 mg administered at morning
Trial: 15581208
Drug: Isoniazid (INH)
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid (INH) 300 mg with alcohol
Trial: 15581208
Drug: Isoniazid (INH)
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid (INH) 300 mg without alcohol
Trial: 15891633
Drug: Radiofrequency tympanostomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiofrequency tympanostomy with topical mitomycin C application (Group C)
Trial: 11982640
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of a single-strain Leishmania amazonensis killed promastigote vaccine plus a half dose of meglumine antimoniate.
Trial: 11982640
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus half dose of meglumine antimoniate.
Trial: 7461567
Drug: Benzbromarone-citrate combination
RxNorm normalized name: benzbromarone
DrugBank: Benzbromarone (DB12319)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzbromarone-citrate combination (Harolan)
Trial: 26847527
Drug: Physiotherapeutic intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physiotherapeutic intervention including daily training program with movements to increase chest flexibility, breathing exercises, and relaxation sessions.
Trial: 25756412
Drug: Inhaled volatile
RxNorm normalized name: Peppermint volatile oil
DrugBank: Peppermint oil (DB11198)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled volatile anesthetic agents (isoflurane or sevoflurane) (n = 67)
Trial: 23815747
Drug: TAP block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAP block (20 mL of either 0.375% ropivacaine or 0.3% levobupivacaine)
Trial: 23815747
Drug: Control (epidural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (epidural morphine 2 mg)
Trial: 21573941
Drug: Red pepper
RxNorm normalized name: Red pepper
DrugBank: Red pepper (DB14759)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red pepper (150 mg of red pepper powder, 4 pills/day for 6 weeks)
Trial: 1547685
Drug: GLP‐I‐(7‐37) infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP‐I‐(7‐37) infusion concurrent with a standard meal
Trial: 1547685
Drug: GLP‐I‐(7‐37) infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP‐I‐(7‐37) infusion
Trial: 30140006
Drug: LPS injection
RxNorm normalized name: LP-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LPS injection
Trial: 9456419
Drug: Retrobulbar injection
RxNorm normalized name: LIDOCAINE HYDROCHLORIDE 40 mg in 1 mL RETROBULBAR INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Retrobulbar injection of lidocaine 4%
Trial: 7943774
Drug: Midazolam 0.1
RxNorm normalized name: midazolam 0.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.1 mg/kg (M high)
Trial: 7943774
Drug: Lorazepam 0.1
RxNorm normalized name: lorazepam 0.1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 0.1 mg/kg (L high)
Trial: 3285835
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg torasemide
Trial: 21914281
Drug: Shenfu (SF)
RxNorm normalized name: light green SF yellowish
DrugBank: Light green SF yellowish (DB11183)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenfu (SF) injection administered by peripheral intravenous infusion at initially 0.2 ml/kg and then 0.8 ml×kg(‐1)×h(‐1) until the end of operations
Trial: 21914281
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline administered similarly to Group S
Trial: 17468908
Drug: D-Stat Dry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-Stat Dry bandage as an adjunct to manual compression
Trial: 8076711
Drug: L-arginine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine supplementation (30 g/day for 3 days prior to each course of chemotherapy)